Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bionano Genomics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:05.434 Good day, and welcome to the BioNano Second Quarter 2026 Earnings Conference Call. 00:00:05.434 -- 00:00:09.416 Today's conference is being recorded. At this time, I would like to turn the conference 00:00:09.416 -- 00:00:11.517 over to Webb Campbell from Gilmartin Group. 00:00:11.517 -- 00:00:13.878 Please go ahead. 00:00:13.878 -- 00:00:16.560 Thank you, operator, and good afternoon, everyone. 00:00:16.560 -- 00:00:21.242 Welcome to the BioNano Second Quarter 2026 Financial Results Conference Call. 00:00:21.242 -- 00:00:26.265 On the call today are Dr. Al Luterer, Chairman and Interim CEO of BioNano, and 00:00:26.265 -- 00:00:32.110 Mark Adamchak, BioNano's Vice President of Accounting and Principal Accounting Officer. 00:00:32.110 -- 00:00:36.632 After market closed today, BioNano issued a press release announcing its financial results 00:00:36.632 -- 00:00:41.554 for the second quarter of 2026. A copy of the release can be found on the Investor Relations 00:00:41.554 -- 00:00:44.035 page of the company's website. 00:00:44.035 -- 00:00:48.697 Certain statements made during this conference call may be forward-looking statements. 00:00:48.697 -- 00:00:53.620 Actual results may differ materially from such statements due to several factors and 00:00:53.620 -- 00:00:59.046 risks, some of which are identified in BioNano's press release and BioNano's report 00:00:59.046 -- 00:01:04.328 filed with the SEC. These forward-looking statements are based upon information 00:01:04.328 -- 00:01:09.450 available to BioNano today, August 10, 2026, and the company 00:01:09.450 -- 00:01:13.852 assumes no obligation to update statements as circumstances change. 00:01:13.852 -- 00:01:18.694 During our call, we may reference certain non-GAAP financial...